<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pmed.1002632.t001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pmed.1002632.t001</object-id>
 <label>Table 1</label>
 <caption>
  <title>Possible trial designs to evaluate the efficacy of investigational vaccines during epidemics of emerging infectious diseases.</title>
  <p>The table does not provide an exhaustive list, and not all designs have been used for evaluating vaccines against emerging infectious diseases.</p>
 </caption>
 <alternatives>
  <graphic id="pmed.1002632.t001g" xlink:href="pmed.1002632.t001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Number</th>
     <th align="left" style="background-color:#BFBFBF" rowspan="1" colspan="1">Trial design type, with examples</th>
     <th align="center" style="background-color:#BFBFBF" rowspan="1" colspan="1">Comparison</th>
     <th align="center" style="background-color:#BFBFBF" rowspan="1" colspan="1">Population</th>
     <th align="center" style="background-color:#BFBFBF" rowspan="1" colspan="1">Implementation</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" colspan="5" style="background-color:#00B0F0" rowspan="1">I. Individually randomized</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">1</td>
     <td align="left" rowspan="1" colspan="1">“Classic” individually randomized controlled trial
      <xref ref-type="table-fn" rid="t001fn001">*</xref>
      <break/>Ex: 
      <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/10749457" xmlns:xlink="http://www.w3.org/1999/xlink">Pneumococcal vaccine, California</ext-link> [
      <xref rid="pmed.1002632.ref010" ref-type="bibr">10</xref>]
      <break/>
      <ext-link ext-link-type="uri" xlink:href="http://www.nejm.org/doi/full/10.1056/NEJMoa1609462" xmlns:xlink="http://www.w3.org/1999/xlink">Rotavirus vaccine, Niger</ext-link> [
      <xref rid="pmed.1002632.ref011" ref-type="bibr">11</xref>]
      <break/>
      <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/26768572" xmlns:xlink="http://www.w3.org/1999/xlink">PREVAIL Ebola vaccine, Liberia</ext-link> [
      <xref rid="pmed.1002632.ref012" ref-type="bibr">12</xref>]
     </td>
     <td align="left" rowspan="1" colspan="1">Placebo or other vaccine (“active control”)</td>
     <td align="left" rowspan="1" colspan="1">General or high-risk</td>
     <td align="left" rowspan="1" colspan="1">Parallel</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">2</td>
     <td align="left" rowspan="1" colspan="1">Serodiscordant couples
      <xref ref-type="table-fn" rid="t001fn002">**</xref>
      <break/>Ex: 
      <ext-link ext-link-type="uri" xlink:href="https://www.nejm.org/doi/full/10.1056/NEJMoa011915" xmlns:xlink="http://www.w3.org/1999/xlink">Herpes simplex virus, type 2</ext-link> [
      <xref rid="pmed.1002632.ref013" ref-type="bibr">13</xref>]
     </td>
     <td align="left" rowspan="1" colspan="1">Placebo</td>
     <td align="left" rowspan="1" colspan="1">High-risk</td>
     <td align="left" rowspan="1" colspan="1">Parallel</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">3</td>
     <td align="left" rowspan="1" colspan="1">Individually randomized, comparison to delayed vaccination
      <break/>Ex: STRIVE 
      <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/mmwr/volumes/65/su/su6503a14.htm" xmlns:xlink="http://www.w3.org/1999/xlink">Ebola vaccine, Sierra Leone, as performed</ext-link> [
      <xref rid="pmed.1002632.ref014" ref-type="bibr">14</xref>]
      <xref ref-type="table-fn" rid="t001fn003">†</xref>
     </td>
     <td align="left" rowspan="1" colspan="1">Delay (without a placebo)</td>
     <td align="left" rowspan="1" colspan="1">High-risk</td>
     <td align="left" rowspan="1" colspan="1">Stepped</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">4</td>
     <td align="left" rowspan="1" colspan="1">Individually randomized controlled trial with deliberately stepped rollout
      <break/>Ex: 
      <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408019/" xmlns:xlink="http://www.w3.org/1999/xlink">Proposed for Ebola vaccines</ext-link> [
      <xref rid="pmed.1002632.ref015" ref-type="bibr">15</xref>]
     </td>
     <td align="left" rowspan="1" colspan="1">Placebo</td>
     <td align="left" rowspan="1" colspan="1">General or high-risk</td>
     <td align="left" rowspan="1" colspan="1">Stepped</td>
    </tr>
    <tr>
     <td align="left" colspan="5" style="background-color:#00B0F0" rowspan="1">II. Cluster randomized</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">5</td>
     <td align="left" rowspan="1" colspan="1">“Classic” parallel, cluster-randomized controlled trial
      <break/>Ex: 
      <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/12907008" xmlns:xlink="http://www.w3.org/1999/xlink">Pneumococcal vaccine, Navajo</ext-link> [
      <xref rid="pmed.1002632.ref016" ref-type="bibr">16</xref>]
     </td>
     <td align="left" rowspan="1" colspan="1">Placebo or other vaccine (“active control”)</td>
     <td align="left" rowspan="1" colspan="1">General</td>
     <td align="left" rowspan="1" colspan="1">Parallel</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">6</td>
     <td align="left" rowspan="1" colspan="1">Stepped-wedge design
      <break/>Ex: 
      <ext-link ext-link-type="uri" xlink:href="http://cancerres.aacrjournals.org/content/47/21/5782?ijkey=1a3a35db58f10d1704a4c3fde1f5420a9ff88ad5&amp;keytype2=tf_ipsecsha" xmlns:xlink="http://www.w3.org/1999/xlink">Hepatitis B vaccine, The Gambia</ext-link> [
      <xref rid="pmed.1002632.ref017" ref-type="bibr">17</xref>]
      <break/>STRIVE 
      <ext-link ext-link-type="uri" xlink:href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(15)70139-8/fulltext" xmlns:xlink="http://www.w3.org/1999/xlink">Ebola vaccine, as initially proposed</ext-link> [
      <xref rid="pmed.1002632.ref018" ref-type="bibr">18</xref>]
     </td>
     <td align="left" rowspan="1" colspan="1">Delay (without a placebo)</td>
     <td align="left" rowspan="1" colspan="1">General</td>
     <td align="left" rowspan="1" colspan="1">Stepped</td>
    </tr>
    <tr>
     <td align="center" rowspan="1" colspan="1">7</td>
     <td align="left" rowspan="1" colspan="1">Ring-vaccination trial versus delayed vaccination
      <break/>Ex: Ebola ça Suffit 
      <ext-link ext-link-type="uri" xlink:href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32621-6/fulltext" xmlns:xlink="http://www.w3.org/1999/xlink">Ebola vaccine, Guinea</ext-link> [
      <xref rid="pmed.1002632.ref019" ref-type="bibr">19</xref>]
      <xref ref-type="table-fn" rid="t001fn003">†</xref>
     </td>
     <td align="left" rowspan="1" colspan="1">Delay (without a placebo)</td>
     <td align="left" rowspan="1" colspan="1">High-risk</td>
     <td align="left" rowspan="1" colspan="1">Ring (stepped)</td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t001fn001">
   <p>*Most common design used for vaccine efficacy trials. (A search on clinicaltrials.gov with filters "Interventional (or Clinical Trial)" for study type, "Phase 3" for study phase, and search term "vaccine" for intervention resulted in 1,251 trials, of which 989 were randomized. Out of a randomly selected 50 of these trials, all were individually randomized and 44 stated use of a parallel rollout.)</p>
  </fn>
  <fn id="t001fn002">
   <p>**Seronegative partner of a seropositive person is at high risk for exposure to infection and is randomized to vaccine or placebo.</p>
  </fn>
  <fn id="t001fn003">
   <p>
    <sup>†</sup>Choice of delayed vaccination comparison due to perceived challenges to the use of placebo in this setting.
   </p>
  </fn>
  <fn id="t001fn004">
   <p>Abbreviations: Ex., example; PREVAIL, Partnership for Research on Ebola Virus in Liberia; STRIVE, Sierra Leone Trial to Introduce a Vaccine Against Ebola.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
